The frequency of mutations in the HRR pathway in melanoma has been estimated to range from 18% to 57%, with some of the most common mutations involving BRCA1/2, ARM, ARID1A, and BARD1 (36–39). The gene discussed is BRCA1; the disease is melanoma.